| Literature DB >> 31881952 |
Amana M Lima1, André O Werneck2, Edilson Cyrino3, Paulo Farinatti4,5.
Abstract
BACKGROUND: Public health strategies to increase physical activity in low-income communities may reduce cardiovascular risk in these populations. This controlled trial compared the cardiovascular risk estimated by the Framingham Risk Score (FRS) over 12 months in formally active (FA), declared active (DA), and physically inactive (PI) patients attended by the 'Family Health Strategy' in low-income communities at Rio de Janeiro City, Brazil (known as 'favelas').Entities:
Keywords: Cardiovascular health; Exercise training; Health promotion; Physical education; Public health; Quasi-experimental trial
Mesh:
Year: 2019 PMID: 31881952 PMCID: PMC6935198 DOI: 10.1186/s12889-019-7716-y
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Fig. 1Sample selection and randomization into experimental groups
Clinical and demographic characteristics of the sample at baseline
| Variable | FA dropout ( | FA complete ( | DA ( | PI ( |
|---|---|---|---|---|
| Sex (%) | ||||
| Female | 93 | 89 | 72 | 73 |
| Male | 7 | 11 | 28 | 27 |
| Ethnicity (%) | ||||
| White | 54 | 55 | 33 | 33 |
| Non-white | 46 | 45 | 67 | 67 |
| Occupation (%) | ||||
| Not working | 50 | 83 | 67 | 83 |
| Working | 50 | 17 | 33 | 17 |
| Medication (%) | ||||
| Betablocker | 29 | 21 | 5 | 25 |
| Antihypertensive | 46 | 76 | 72 | 71 |
| Hypoglycemiant | 39 | 34 | 9 | 31 |
| Statin | 46 | 38 | 26 | 29 |
| Clinical Status (%) | ||||
| Diabetes | 39 | 30 | 14 | 26 |
| Hypertension | 46 | 77 | 70 | 67 |
| Smoking | 7 | 6 | 2 | 2 |
| Overweight | 21 | 36 | 40 | 27 |
| Obesity | 60 | 47 | 49 | 54 |
FA formally active (intervention group), DA active controls (self-directed physical activity), PI inactive controls
Characteristics of the sample at baseline according to experimental groups
| FA ( | DA ( | PI ( | ||
|---|---|---|---|---|
| Chronological age, years | 59.4 ± 7.6 | 57.0 ± 11.2 | 57.0 ± 10.7 | 0.245 |
| BMI, kg/m2 | 30.2 ± 5.8 | 31.0 ± 6.2 | 30.5 ± 6.2 | 0.806 |
| Total cholesterol, mg/Dl | 204.9 ± 43.7 | 199.6 ± 38.6 | 201.3 ± 54.9 | 0.065 |
| HDL-C, mg/dL | 50.6 ± 13.3 | 49.3 ± 12.1 | 46.6 ± 13.8 | 0.270 |
| LDL-C, mg/dL | 126.3 ± 37.8 | 123.7 ± 34.7 | 121.8 ± 52.0 | 0.190 |
| Triglycerides, mg/dL | 141.6 ± 55.1 | 133.0 ± 59.0 | 164.9 ± 95.0 | 0.651 |
| SBP, mmHg | 132.2 ± 17.0 | 135.4 ± 15.8 | 131.9 ± 17.8 | 0.401 |
| DBP, mmHg | 82.8 ± 10.0 | 84.7 ± 6.7 | 84.8 ± 7.7 | 0.373 |
| Framingham Risk Score | 0.16 ± 0.12 | 0.14 ± 0.13 | 0.16 ± 0.12 | 0.134 |
Note. FA formally active (intervention group), DA active controls (self-directed physical activity), PI inactive controls. BMI body mass index, HDL-C high density lipoprotein – cholesterol, HDL-C low density lipoprotein – cholesterol, SBP systolic blood pressure, DBP diastolic blood pressure. Data are reported as mean ± standard deviation
Classification of exercises performed by formally active (FA) and declared active (DA) groups according to training variables
| FA ( | DA ( | |
|---|---|---|
| Frequency (sessions/week) | ||
| 2 | – | 51% |
| 3 | 100% | 39% |
| > 3 | – | 10% |
| Intensitya | ||
| Light (Borg 1-3) | 14% | 69% |
| Moderate (Borg 5-6) | 63% | 31% |
| Vigorous (Borg 7-8) | 23% | 0% |
| Time (min) | ||
| 30–60 min | – | 75% |
| 60–90 min | 100% | 15% |
| > 90 min | – | 10% |
| Type (modalities) | ||
| Walking | NA | 13% |
| Jogging | NA | 77% |
| Calisthenics/Functional | NA | 10% |
Note. aIntensity estimated by means of the Borg CR-10 Scale (0–10), NA not applicable
Adjusted generalized estimating equations of the effect of different interventions in lipid profile and blood pressure
| Variable | FA ( | DA ( | PI ( | Power (1-β) | ||||
|---|---|---|---|---|---|---|---|---|
| Baseline | Follow-up | Baseline | Follow-up | Baseline | Follow-up | Interaction | ||
| Total cholesterol, mg/dL | 202.3 (192.9 to 212.2) | 200.7 (189.4 to 212.8) | 193.0 (180.3 to 206.6) | 183.1 (168.7 to 198.7) | 0.91 | |||
| HDL-C, mg/dL | 49.7 (47.1 to 52.5) | 50.4 (47.8 to 53.1) | 50.2 (46.7 to 53.9) | 49.5 (45.8 to 53.6) | 47.3 (43.5 to 51.4) | 45.5 (41.9 to 49.5) | 0.537 | 0.21 |
| LDL-C, mg/dL | 124.9 (116.9 to 133.4) | 124.3 (114.1 to 135.3) | 112.3 (101.0 to 124.9) | 0.86 | ||||
| Triglycerides, mg/dL | 145.6 (130.0 to 154.3) | 133.3 (116.9 to 152.0) | 141.0 (121.8 to 163.1) | 131.5 (115.7 to 149.4) | 0.99 | |||
| PAS, mmHg | 131.9 (128.5 to 135.3) | 135.6 (131.1 to 140.3) | 134.4 (129.4 to 139.5) | 132.2 (127.5 to 137.1) | 1.00 | |||
| PAD, mmHg | 82.9 (80.8 to 84.9) | 84.6 (82.6 to 86.6) | 82.8 (79.5 to 86.3) | 84.8 (82.8 to 87.0) | 86.2 (83.6 to 88.9) | 0.83 | ||
FA formally active group, DA declared active group, PI physically inactive group. BMI body mass index, HDL-C high density lipoprotein – cholesterol, LDL-C low density lipoprotein – cholesterol, SBP systolic blood pressure, DBP diastolic blood pressure. Note: Intention-to-treat: FA includes individuals that completed the supervised training (n = 53) and dropouts (n = 28). Interaction refers to the interaction group vs. time. Analyses adjusted for sex, chronological age, body mass index and hypertensive/statin drugs ingestion. Values presented through estimated marginal means (95% confidence interval).
(Bold data) *P < 0.05 vs. Baseline, aP < 0.05 vs. PI, bP < 0.05 vs. DA
Fig. 2Adjusted generalized estimating equations of the effect of different interventions upon the Framingham risk score. FA: intervention group, including patients that completed the supervised training (n = 53) and dropouts (n = 28) (intention-to-treat approach); DA: active controls, self-directed physical activity performed twice a week (n = 43); PI: inactive controls, patients remained physically inactive throughout the experiment. Solid lines indicate significant differences between groups. *: P < 0.05 vs. baseline. Analyzes adjusted for sex, chronological age, body mass index and hypertensive/statin drugs ingestion. Power (1-beta): 1.00